LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

Search

Zoetis Inc

Aperta

SettoreSettore sanitario

80.57 5.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

76.36

Massimo

81.52

Metriche Chiave

By Trading Economics

Entrata

-2M

601M

Vendite

-125M

2.3B

P/E

Media del settore

12.715

49.888

EPS

1.42

Rendimento da dividendi

2.61

Margine di Profitto

26.569

Dipendenti

14,500

EBITDA

-6M

941M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+59.25% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

2.61%

2.38%

Utili prossimi

4 ago 2026

Prossima data del Dividendo

1 set 2026

Prossima data del' Ex Dividendo

20 lug 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-15B

33B

Apertura precedente

75.28

Chiusura precedente

80.57

Notizie sul Sentiment di mercato

By Acuity

52%

48%

259 / 344 Classifica in Healthcare

Zoetis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 ago 2025, 11:06 UTC

Utili

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 ago 2025, 11:06 UTC

Utili

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 ago 2025, 11:05 UTC

Utili

Zoetis 2Q Adj EPS $1.76 >ZTS

Confronto tra pari

Modifica del prezzo

Zoetis Inc Previsione

Obiettivo di Prezzo

By TipRanks

59.25% in crescita

Previsioni per 12 mesi

Media 123.56 USD  59.25%

Alto 150 USD

Basso 95 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zoetis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

12 ratings

6

Acquista

6

Mantieni

0

Vendi

Sentiment

By Acuity

259 / 344 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat